Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 105
11
Diseases
137
Unique genes
0.141
Avg. similarity score
Hereditary hemolytic anemia
Most-connected disease (6 links)
Disease
Searched: inherited glutathione synthetase deficiency
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
inherited glutathione synthetase deficiency
Hereditary hemolytic anemia
Bisphosphoglycerate mutase deficiency
Erythrocytosis
Hemolytic anemia
Polycythemia
Secondary polycythemia
Anemia
Charcot-Marie-Tooth disease type 4B2
Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome
Coronary vessel anomalies
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Hereditary hemolytic anemia | 6 | 6 | 11 |
| Bisphosphoglycerate mutase deficiency | 4 | 4 | 1 |
| Erythrocytosis | 4 | 4 | 13 |
| Hemolytic anemia | 4 | 4 | 55 |
| Polycythemia | 4 | 4 | 19 |
| Secondary polycythemia | 4 | 4 | 8 |
| Anemia | 2 | 2 | 84 |
| Charcot-Marie-Tooth disease type 4B2 | 1 | 1 | 1 |
| Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome | 1 | 1 | 1 |
| Coronary vessel anomalies | 1 | 1 | 1 |
| inherited glutathione synthetase deficiency | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HBB | 6 / 11 | Anemia, Erythrocytosis, Hemolytic anemia, Hereditary hemolytic anemia and 2 more |
| BPGM | 5 / 11 | Bisphosphoglycerate mutase deficiency, Erythrocytosis, Hemolytic anemia, Hereditary hemolytic anemia and 1 more |
| EPO | 5 / 11 | Anemia, Erythrocytosis, Hemolytic anemia, Polycythemia and 1 more |
| HBA1 | 4 / 11 | Anemia, Erythrocytosis, Polycythemia, Secondary polycythemia |
| HK1 | 4 / 11 | Anemia, Hemolytic anemia, Hereditary hemolytic anemia, Polycythemia |
| EGLN1 | 3 / 11 | Erythrocytosis, Polycythemia, Secondary polycythemia |
| EPAS1 | 3 / 11 | Erythrocytosis, Polycythemia, Secondary polycythemia |
| EPOR | 3 / 11 | Anemia, Erythrocytosis, Polycythemia |
| GCLC | 3 / 11 | Coronary vessel anomalies, Hemolytic anemia, Hereditary hemolytic anemia |
| HBA2 | 3 / 11 | Anemia, Erythrocytosis, Secondary polycythemia |
| JAK2 | 3 / 11 | Anemia, Erythrocytosis, Polycythemia |
| VHL | 3 / 11 | Erythrocytosis, Polycythemia, Secondary polycythemia |
| ABO | 2 / 11 | Anemia, Hemolytic anemia |
| ACE | 2 / 11 | Anemia, Polycythemia |
| ANK1 | 2 / 11 | Anemia, Hemolytic anemia |
| FAM234A | 2 / 11 | Anemia, Hereditary hemolytic anemia |
| G6PD | 2 / 11 | Anemia, Hemolytic anemia |
| GATA1 | 2 / 11 | Anemia, Hemolytic anemia |
| GH1 | 2 / 11 | Anemia, Polycythemia |
| GPI | 2 / 11 | Hemolytic anemia, Hereditary hemolytic anemia |
| GPX1 | 2 / 11 | Anemia, Hereditary hemolytic anemia |
| GSR | 2 / 11 | Anemia, Hemolytic anemia |
| GSS | 2 / 11 | Hereditary hemolytic anemia, inherited glutathione synthetase deficiency |
| H2BC4 | 2 / 11 | Anemia, Polycythemia |
| HFE | 2 / 11 | Anemia, Polycythemia |
| HP | 2 / 11 | Anemia, Hemolytic anemia |
| IFNA2 | 2 / 11 | Anemia, Hemolytic anemia |
| INSL6 | 2 / 11 | Erythrocytosis, Polycythemia |
| ITPA | 2 / 11 | Anemia, Hemolytic anemia |
| LUC7L | 2 / 11 | Anemia, Hereditary hemolytic anemia |
| PRKCE | 2 / 11 | Anemia, Polycythemia |
| SBF2 | 2 / 11 | Charcot-Marie-Tooth disease type 4B2, Hemolytic anemia |
| SHH | 2 / 11 | Anemia, Hemolytic anemia |
| SLC30A10 | 2 / 11 | Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome, Polycythemia |
| SPTA1 | 2 / 11 | Anemia, Hemolytic anemia |
| SPTB | 2 / 11 | Anemia, Hemolytic anemia |
| TMPRSS6 | 2 / 11 | Anemia, Polycythemia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Ferroptosis | KEGG | 8 / 42 | 16.7× | 1.99e-8 | 1.68e-6 ✓ sig. |
| Erythrocytes take up oxygen and release carbon dioxide | Reactome | 5 / 9 | 48.7× | 2.18e-8 | 1.83e-6 ✓ sig. |
| Scavenging of heme from plasma | Reactome | 5 / 13 | 33.7× | 2.15e-7 | 1.36e-5 ✓ sig. |
| Erythrocytes take up carbon dioxide and release oxygen | Reactome | 5 / 13 | 33.7× | 2.15e-7 | 1.36e-5 ✓ sig. |
| Glycolysis | Reactome | 6 / 28 | 18.8× | 6.05e-7 | 3.35e-5 ✓ sig. |
| Pathways in cancer | KEGG | 19 / 533 | 3.1× | 9.58e-6 | 3.42e-4 ✓ sig. |
| Iron uptake and transport | Reactome | 5 / 28 | 15.7× | 1.43e-5 | 4.76e-4 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 15 / 361 | 3.6× | 1.53e-5 | 5.05e-4 ✓ sig. |
| Hematopoietic cell lineage | KEGG | 8 / 100 | 7.0× | 1.80e-5 | 5.76e-4 ✓ sig. |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 8 / 101 | 6.9× | 1.94e-5 | 6.14e-4 ✓ sig. |
| JAK-STAT signaling pathway | KEGG | 10 / 168 | 5.2× | 2.18e-5 | 6.79e-4 ✓ sig. |
| Estrogen-stimulated signaling through PRKCZ | Reactome | 3 / 6 | 43.8× | 2.83e-5 | 8.40e-4 ✓ sig. |
| HIF-1 signaling pathway | KEGG | 8 / 110 | 6.4× | 3.60e-5 | 1.02e-3 ✓ sig. |
| African trypanosomiasis | KEGG | 5 / 37 | 11.8× | 5.84e-5 | 1.51e-3 ✓ sig. |
| Mineral absorption | KEGG | 6 / 61 | 8.6× | 6.55e-5 | 1.66e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| multicellular organismal-level iron ion homeostasis | GO:0060586 | 11 / 28 | 53.6× | 4.22e-17 | 4.22e-14 ✓ sig. |
| erythrocyte development | GO:0048821 | 9 / 32 | 38.4× | 1.14e-12 | 5.23e-10 ✓ sig. |
| intracellular iron ion homeostasis | GO:0006879 | 9 / 71 | 17.3× | 2.38e-9 | 4.84e-7 ✓ sig. |
| response to hydrogen peroxide | GO:0042542 | 7 / 39 | 24.5× | 1.23e-8 | 2.05e-6 ✓ sig. |
| cell surface receptor signaling pathway via STAT | GO:0097696 | 6 / 28 | 29.2× | 4.59e-8 | 6.34e-6 ✓ sig. |
| response to nutrient levels | GO:0031667 | 8 / 79 | 13.8× | 1.14e-7 | 1.38e-5 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 12 / 248 | 6.6× | 2.94e-7 | 3.08e-5 ✓ sig. |
| response to cadmium ion | GO:0046686 | 5 / 21 | 32.5× | 3.64e-7 | 3.68e-5 ✓ sig. |
| iron ion export across plasma membrane | GO:1903988 | 3 / 3 | 136× | 3.86e-7 | 3.85e-5 ✓ sig. |
| glycolytic process | GO:0006096 | 6 / 49 | 16.7× | 1.50e-6 | 1.19e-4 ✓ sig. |
| response to isolation stress | GO:0035900 | 3 / 4 | 102× | 1.53e-6 | 1.21e-4 ✓ sig. |
| carbon dioxide transport | GO:0015670 | 4 / 13 | 42.0× | 1.88e-6 | 1.42e-4 ✓ sig. |
| iron ion transport | GO:0006826 | 5 / 31 | 22.0× | 2.87e-6 | 1.98e-4 ✓ sig. |
| maintenance of blood vessel diameter homeostasis by renin-angiotensin | GO:0002034 | 3 / 5 | 81.8× | 3.81e-6 | 2.49e-4 ✓ sig. |
| nitric oxide transport | GO:0030185 | 3 / 5 | 81.8× | 3.81e-6 | 2.49e-4 ✓ sig. |